OCI-Ly10 In Vitro Protein Expression Analysis Assay (Immunoassays)

CAT#: ITS-0123-YF5132
Target Cell Organism: Human
Target Cell Name: OCI-Ly10
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide OCI-Ly10-based In Vitro Protein Expression Analysis Assay (Immunoassays) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
OCI-Ly10
Target Cell Organism
Human
Target Cell Background
human B-cell non-Hodgkin lymphoma cell line established from the bone marrow of a 44-year-old man with B-cell non-Hodgkin lymphoma (B-NHL; diffuse large cell), stage 4B at relapse in 1983
Related Diseases
Lymphoma
Research Area
Oncology
Assay Name
In Vitro Protein Expression Analysis Assay (Immunoassays)
Assay Description
For protein expression, western blotting and immunoassays have provided high-quality quantitative results. 2D gel electrophoresis
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.
For Research Use Only | Not For Clinical Use
Online Inquiry